Archives of Dermatological Research

, Volume 276, Issue 6, pp 401–405 | Cite as

The local antiandrogenic effect of the intracutaneous injection of progesterone in the flank organ of sexually mature male syrian golden hamster

  • N. Orentreich
  • J. R. Matias
  • V. Malloy
Original Contributions


The local antiandrogenic action of progesterone was investigated using the androgen-responsive flank organs of adult, sexually mature male Syrian golden hamsters. The effect of the unilateral injections of a micronized suspension of progesterone into the flank organs was analyzed by the measurement of the weight, area of surface pigmentation, and the cross-sectional area of the sebaceous glands. The weekly injections of 5 mg of progesterone for a period of 3 weeks produced approximately 50% reduction in all three parameters in comparison to the controls. The minimal effective dose of 1 mg per week was determined by the injection of progesterone at doses ranging from 0.1 to 5 mg. These effects were localized only to the treated flank organs since the values for the contralateral side were not significantly different from the controls. The local action of progesterone was further demonstrated by the absence of effect on the weight of seminal vesicles and testes of the treated animals in comparison to the controls.

Key words

Antiandrogen Progesterone Sebaceous glands Hamsters 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berger RA, Orentreich N (1968) Local injections of steroids in dermatologic disorders. In: Waisman M (ed) Pharmaceutical therapeutics in dermatology. CC Thomas, Springfield, Illinois, pp 36–43Google Scholar
  2. 2.
    Fayolle J (1975) La Progesterone percutanee dans le traitement de l'acne et des etats seborrheiques de la peau et du cuir chevello. Lyon Medical 233:1303–1305Google Scholar
  3. 3.
    Girard A, Barbieri A, Lafille C (1980) Inhibition of testosterone metabolism and lipogenesis in animal sebaceous glands by progesterone. Arch Dermatol Res 269:281–290Google Scholar
  4. 4.
    Goos CMAA, Wirtz P, Vermoken AJM (1982) An improved method for evaluating antiandrogens. Arch Dermatol Res 273:333–341Google Scholar
  5. 5.
    Guilaine J (1975) Experimentation du produit progestosol sur 50 malades atteints de seborrhee du cuir chevelu et d'acne du visage et du dos. Med Interne 10:572–574Google Scholar
  6. 6.
    Malloy V, Matias JR, Orentreich N (1983) The inhibitory effect of topical progesterone on the flank organ of intact sexually mature male Syrian hamsters. Clin Res 31:585Google Scholar
  7. 7.
    Mauvais-Jarvis P, Baudot N, Bercovivi JP (1969) In vivo studies on progesterone metabolism by human skin. J Clin Endocrinol 29:1580–1585Google Scholar
  8. 8.
    Mauvais-Jarvis P, Kutten F, Baudot N (1974) Inhibition of testosterone conversion to dihydrotesterone in men treated percutaneously by progesterone. J Clin Endocrinol Metab 38:142–147Google Scholar
  9. 9.
    Simpson NBM, Bowden PE, Forster RA, Cunliffe WJ (1979) The effect of topically applied progesterone on sebum excretion rate. Br J Dermatol 100:687–692Google Scholar
  10. 10.
    Vermorken AJM, Goos CMAA, Roelofs HMJ (1980) The antiandrogenic effect of progesterone on the hamster flank organ. Br J Dermatol 102:455–460Google Scholar
  11. 11.
    Voigt W, Fernandez EP, Hsia SL (1970) Transformation of testosterone into 17B-OH-5 α-androstan-3-one by microsomal preparations of human skin. J Biol Chem 245:5594–5599Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • N. Orentreich
    • 1
  • J. R. Matias
    • 2
  • V. Malloy
    • 2
  1. 1.Department of DermatologyNew York University Medical CenterNew York
  2. 2.Orentreich Foundation for the Advancement of Science, Inc.New YorkUSA

Personalised recommendations